Drug Metabolism Letters
Volume 14, 3 Issues, 2020
ISSN: 1874-0758 (Online)
ISSN: 1872-3128 (Print)
This journal supports open access
ISSN: 1874-0758 (Online)
ISSN: 1872-3128 (Print)
This journal supports open access
In the current pandemic scenario, publication process of all articles related to Coronavirus will be expedited, for timely publication of much needed research
Contents
Drug Metabolism Letters, Volume 1 - Number 4
Inhibition of Calcium Oxalate Nephrotoxicity with Cymbopogon Schoenanthus (Al-Ethkher)
, 1(4): 241 - 244Saeed S. Al-Ghamdi, Abdullah A. Al-Ghamdi and Ahmed A. Shammah
DOI: 10.2174/187231207783221420
Modelling and Measuring Redox Cycling and Cytotoxicity of Quinones
, 1(4): 245 - 253Louise Hughes, Jordana Wingate, Renate Griffith and R. John Aitken
DOI: 10.2174/187231207783221457
Endothelial Cell-Based Methods for the Detection of Cyanobacterial Anti- Inflammatory and Wound-Healing Promoting Metabolites
, 1(4): 254 - 260Christoph Wiesner, Jiri Kopecky, Maren Pflueger, Harald Hundsberger, Barbara Entler, Christoph Kleber, Josef Atzler, Pavel Hrouzek, Dalibor Stys, Alena Lukesova, Wolfgang Schuett and Rudolf Lucas
DOI: 10.2174/187231207783221385
The N-Terminal of Human UGT1A6 Is on the Outside, as Evidenced by ELISA with Autoantibody in Autoimmune Hepatitis Sera
, 1(4): 261 - 266Hitomi Mori, Masakazu Shinoda and Takaharu Mizutani
DOI: 10.2174/187231207783221484
Clinically Significant Proteinuria Following the Administration of Sirolimus to Renal Transplant Recipients
, 1(4): 267 - 271Alan S. Perlman, Eugene H. Kim, Bhaskar Kallakury, Jimmy A. Light, Jack Moore and Jr.
DOI: 10.2174/187231207783221439
Metabolite Interference in Pharmacokinetic Studies
, 1(4): 272 - 275Mehran F. Moghaddam, Jui-Hsiang Fan, Yang Tang, Oleg Khatsenko, Jason C. Katz and Michael A. Shirley
DOI: 10.2174/187231207783221475
Allelic Variations in CYP2D6 Gene and Susceptibility to Cervical Cancer
, 1(4): 276 - 280S. Wajid, S. H. Naqvi, A. Juneja, M. Bharadwaj and A. B. Mitra
DOI: 10.2174/187231207783221367
Comprehensive Identification of Cytochrome P450 Isoforms from Solubility-Based Fractionated Rat Liver Microsomes
, 1(4): 281 - 286Hidenori Yamanaka, Masahiro Takeyoshi, Yasushi Minobe, Yoshikuni Yakabe, Mineo Takatsuki and Hisaya Sato
DOI: 10.2174/187231207783221394
Mass Defect Filtering on High Resolution LC/MS Data as a Methodology for Detecting Metabolites with Unpredictable Structures: Identification of Oxazole-Ring Opened Metabolites of Muraglitazar
, 1(4): 287 - 292Donglu Zhang, Peter T. Cheng and Haiying Zhang
DOI: 10.2174/187231207783221466
LC-MS/MS-Based Approach for Obtaining Exposure Estimates of Metabolites in Early Clinical Trials Using Radioactive Metabolites as Reference Standards
, 1(4): 293 - 298Donglu Zhang, Nirmala Raghavan, Theodore Chando, Janice Gambardella, Yunlin Fu, Duxi Zhang, Steve E. Unger and W. Griffith Humphreys
DOI: 10.2174/187231207783221411
In Vitro Metabolism of Leflunomide by Mouse and Human Liver Microsomes
, 1(4): 299 - 305Eric C.Y. Chan and Lee-Sun New
DOI: 10.2174/187231207783221402
A New Method to Measure P-gp (ABCB1) Activity
, 1(4): 306 - 310Masatoshi Masuda and Takaharu Mizutani
DOI: 10.2174/187231207783221448
Glucocorticoid Receptor Functions in HeLa Cells Are Perturbed by 2,3,8,9-tetrachlorodibenzo-p-dioxin (TCDD)
, 1(4): 311 - 314Radim Vrzal, Jitka Ulrichova, Zdenek Dvorak and Petr Pavek
DOI: 10.2174/187231207783221376
Editor-in-Chief
Zhiyang Zhao
Alliance Pharma
Malvern, PA
(USA)
Biography
Alliance Pharma
Malvern, PA
Biography
Biography of Zhiyang Zhao
Zhiyang Zhao received his Ph.D. degree in Medicinal Chemistry from Virginia Tech, Blacksburg, Virginia, USA. Dr. Zhao’s biopharmaceutical/pharmaceutical work experience encompasses over 25 years of research in metabolic and pharmacokinetic properties of compounds for drug discovery and development at Pfizer, GlaxoSmithKline and Amgen. Currently, Dr. Zhao serve as Chief Scientific Officer (CSO) at Alliance Pharma, Inc. and appointed as an adjunct professor at the School of Pharmacy, the University of North Carolina at Chapel Hill. Dr. Zhao has published over 50 peer reviewed original research papers and patents in the areas of new drug targets, drug metabolism, pharmacokinetics, and toxicology.
COPE Compliant
About the Journal
For Authors
For Librarians & Readers
Quick Links
Journal History
Drug Metabolism Letters was launched in 2007. Dr. Zhiyang Zhao serves as the Editor-in-Chief of the journal.
Scopus CiteScore Metrics: 1.01
Advertisement
Webmaster Contact: info@benthamscience.net